Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-044318
Filing Date
2025-05-15
Accepted
2025-05-15 16:49:25
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0240744-10q_abpro.htm   iXBRL 10-Q 1047285
2 CERTIFICATION ea024074401ex31-1_abpro.htm EX-31.1 10178
3 CERTIFICATION ea024074401ex32-1_abpro.htm EX-31.2 4065
  Complete submission text file 0001213900-25-044318.txt   7058345

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abp-20250331.xsd EX-101.SCH 75896
5 XBRL CALCULATION FILE abp-20250331_cal.xml EX-101.CAL 33296
6 XBRL DEFINITION FILE abp-20250331_def.xml EX-101.DEF 390403
7 XBRL LABEL FILE abp-20250331_lab.xml EX-101.LAB 663930
8 XBRL PRESENTATION FILE abp-20250331_pre.xml EX-101.PRE 396386
80 EXTRACTED XBRL INSTANCE DOCUMENT ea0240744-10q_abpro_htm.xml XML 683220
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41224 | Film No.: 25954711
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)